Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma

Clinical trial NCT00001832 · COMPLETED

Trial details

NCT number: NCT00001832
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Neoplasm Metastasis

Start date: 1999-08-01
Primary completion: 2010-05-01
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.